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Background: Wake-up stroke (WUS) represents 25% of all ischemic strokes. There
is conflicting evidence concerning clinical severity, imaging characteristics, and
outcome when WUS is compared with stroke of known time of onset. Our aim
was to compare WUS patients with patients with ischemic stroke within the ther-
apeutic window (STW) for thrombolysis. Methods: This is a retrospective hospital-
based study of all consecutive patients hospitalized for acute ischemic stroke during
2013. Patients with STW, WUS, and WUS with computed tomography (CT) at 3
hours or less after awakening (WUS≤3h) were selected for the study. The methods
used include a review of clinical records, an independent quantification of early
signs of ischemia on admission CT scan, and determination of functional outcome
on follow-up. Results: Of 554 patients evaluated, 190 had STW, 113 had WUS (20.4%),
and 25 had WUS≤3h. Among all WUS patients, 33.6% did not have any other
formal contraindication for thrombolysis besides undetermined time of onset. WUS
patients had demographic characteristics, vascular risk factors, and clinical se-
verity similar to STW patients. Mild or absent early signs of ischemia on admission
CT in WUS≤3h patients were similar to those in STW patients when adjusted for
clinical severity (odds ratio [OR] = .50, 95% confidence interval [CI]=.17-1.47). Fa-
vorable prognosis in WUS≤3h was similar to STW when adjusted for age, clinical
severity, and thrombolysis (OR = .53, 95% CI=.09-3.14). Conclusions: This study
strengthens the evidence that clinical and early imaging characteristics of WUS
patients are similar to those of patients with stroke who are eligible for throm-
bolysis based on the time window criteria, and patients with WUS do not have
a worse short outcome. Key Words: Wake-up stroke—ischemic stroke—computed
tomography—stroke outcome.
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Introduction
Wake-up stroke (WUS) represents up to 25% of all isch-
emic strokes,1 and unknown onset of stroke symptoms
with time since last seen well for more than 4 hours and
30 minutes is considered a contraindication for throm-
bolysis. There is an increasing interest in research to define
whether WUS patients benefit from reperfusion thera-
pies in the acute phase, and randomized controlled trials
are being conducted.2,3 Studies comparing characteris-
tics of WUS and stroke with known time of onset are
not unanimous,4 but can help in selecting inclusion and
exclusion criteria for therapeutic trials. The aim of this
study was to compare clinical and computed tomography
From the *School of Health Sciences, University of Minho, Portugal;
†Neurology Department, Hospital de Braga, Portugal; and
‡Neuroradiology Department, Hospital de Braga, Portugal.
Received March 21, 2015; revision received September 25, 2015;
accepted October 31, 2015.
Address correspondence to João Pinho, Hospital de Braga, Sete
Fontes, São Victor, 4710-243 Braga, Portugal. E-mail: jdpinho@
gmail.com.
1052-3057/$ - see front matter
© 2016 National Stroke Association. Published by Elsevier Inc. All
rights reserved.
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.10.032
Journal of Stroke and Cerebrovascular Diseases, Vol. 25, No. 3 (March), 2016: pp 511–514 511
C(CT) findings of patients with WUS and patients with
stroke of known time of onset and within the therapeu-
tic window for thrombolysis.
Methods
In this retrospective hospital-based study, records of
all consecutive patients hospitalized for acute ischemic
stroke during 2013 were reviewed. The patients were
categorized in the following groups: clear description
of presence of symptoms on awakening was character-
ized as “WUS”; registered time of onset and CT scan at
4 hours and 30 minutes or less after symptom onset
was characterized as “stroke within the therapeutic
window” (STW); WUS with time from awakening to
CT at 3 hours or less was characterized as “WUS≤3h.
Patients with known onset-to-CT time of more than 4
hours and 30 minutes, unknown onset, and no register
of time of onset were excluded. Information on time
since last known normal in patients with WUS was not
systematically available in the clinical records, except
for patients who had symptoms on awakening but had
a time since last known normal to CT of less than 4
hours and 30 minutes. These patients were categorized
as STW. Information on demographic data and clinical
characteristics was collected. Severity of neurological
deficits was quantified by reviewing neurological exam-
ination of the patient in the emergency department,
systematically performed by neurologists in our hospi-
tal. Systematic information for scoring National Institutes
of Health Stroke Scale (NIHSS) was unavailable, and a
mini-NIHSS was applied, in which the item “8. Sensory”
was simplified (0 = normal, 1 = mild to total sensory
lost), and the following items were omitted: “1b.Level
of consciousness questions,” “1c.Level of consciousness
commands,” “2.Best gaze,” and “7.Limb ataxia.” All
admission CT scans were independently reviewed by 2
neuroradiologists, aware of the arterial territory in-
volved and the side of the ischemic stroke, and unaware
of clinical deficits. Alberta Stroke Program Early CT
Score (ASPECTS),5 in the case of carotid territory stroke,
and posterior circulation ASPECTS (pcASPECTS),6 in
the case of vertebrobasilar territory stroke, were evalu-
ated, and disagreements were settled by consensus.
Interobserver agreement was determined using Cohen’s
kappa coefficient. Absent or mild early signs of isch-
emia on admission CT were considered as an ASPECTS
of 7 or more and a pcASPECTS of 7 or more. Etiology
was classified according to the Trial of Org 10172 in
Acute Stroke Treatment.7 Modified Rankin scale (mRS)
scores were collected from outpatient clinic records of
follow-up visits; an mRS score of 2 or lower was con-
sidered a favorable outcome. Distribution of continuous
variables was analyzed using the Kolmogorov–Smirnov
test. The Pearson chi-square, the Fisher exact test, and
the Mann–Whitney test were used to determine group
differences in demographic and clinical variables, de-
pending on the comparison and test assumptions. A
binary logistic regression model was developed for ana-
lyzing ASPECTS/pcASPECTS and follow-up mRS scores
in the WUS≤3h and STW groups, adjusting for relevant
variables. The standard noncorrected significance level
of P less than .05 was used. Statistical analysis was
performed using SPSS Statistics version 20.0 (IBM Cor-
poration, New York, United States of America)
Results
Five hundred fifty-four patients were admitted for acute
ischemic stroke during the study period. Among all stroke
patients, WUS occurred in 113 patients (20.4%), 25 of which
underwent CT scan at 3 hours or less after awakening
(WUS≤3h), and 190 patients had STW for thrombolysis.
Two hundred fifty-one patients were excluded: 141 had
unknown onset or no record of onset time, and 110 had
known onset-to-CT time of more than 4 hours and 30
minutes. Demographic and clinical characteristics are shown
in Table 1. WUS and STW patients had a relatively high
median age (80 and 78 years, respectively) and high prev-
alence of classical vascular risk factors. Gender, age, vascular
risk factors, and CHA2DS2Vasc score were similar in both
groups. There was no significant difference in the dis-
tribution of mini-NIHSS scores in the WUS and STW
groups, however, WUS patients had more frequent pos-
terior circulation infarcts in Oxford Community Stroke
Project classification (P < .0005). Accordingly, vertebrobasilar
circulation stroke occurred more frequently in WUS pa-
tients (P < .0005). In the 230 patients who had adequate
etiological investigation, the most frequent cause for stroke
was cardioembolism (n = 143, 62.2%), and etiology was
similar in the WUS and STW groups. Median time to
follow-up was 135 days (interquartile range = 77.5-
168.0). There was no difference in prevalence of favorable
outcome on follow-up (WUS = 37.8%, STW = 43.8; P = .359).
For comparing early signs of ischemia in admission CT,
the WUS≤3h subgroup was compared with the STW group.
Interobserver agreement for ASPECTS and pcASPECTS
was good (kappa = .86, P < .0005). An ASPECTS of 7 or
more or a pcASPECTS of 7 or more was less frequent
in the WUS≤3h group (P = .014); however, this sub-
group had a significantly greater median mini-NIHSS score
(Table 1). In the multivariate analysis adjusted for mini-
NIHSS, WUS≤3h was less likely than STW to present
ASPECTS≥7 or pcASPECTS≥7, but this difference was not
significant (odds ratio = .50, 95% confidence interval = .17-
1.47, P = .208) (Table 2). Favorable outcome was analyzed
in the WUS≤3h group using STW as the reference group,
and after adjusting for mini-NIHSS, age and intrave-
nous thrombolysis, no differences were found (odds
ratio = .53, 95% confidence interval = .09-3.14, P = .486)
(Table 2). Among all WUS patients, 38 (33.6%) had no
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formal contraindication for thrombolysis other than un-
determined time of onset.
Discussion
This study confirms the significant prevalence of WUS
(one fifth of all ischemic strokes), which, given the po-
tential eligibility for reperfusion therapies in one third
of these patients, could significantly increase the number
of patients who benefit from thrombolysis. We found that
clinical severity in WUS patients was not different from
that in patients with STW. Additionally, signs of early
ischemia in CT performed in the hyperacute phase were
also similar. Given that we routinely do not subject WUS
patients to thrombolysis in our hospital, there was a wide
range of time from awakening to CT, and for comparing












Age (years) 78 (69-83) 80 (65-85) .150 81 (68-84) .109
Female sex, n (%) 116 (61.1) 71 (62.8) .758 18 (72.0) .288
Arterial hypertension, n (%) 149 (78.4) 86 (76.1) .640 17 (68.0) .243
Diabetes mellitus, n (%) 48 (25.3) 30 (26.5) .805 10 (40.0) .119
Dyslipidemia, n (%) 92 (48.4) 57 (50.4) .734 12 (48.0) .968
Coronary heart disease/peripheral
atherosclerotic disease, n (%)
18 (9.5) 8 (7.1) .472 1 (4.0) .321
CHA2DS2Vasc score 6 (4-7) 6 (4-6) .212 6 (4-7) .086
OCSP
Total anterior circulation infarct 93 (48.9) 39 (34.5) .014 13 (52.0) .774
Partial anterior circulation infarct 49 (25.8) 29 (25.7) .981 6 (24.0) .533
Lacunar infarct 32 (16.8) 16 (14.2) .536 1 (4.0) .073
Posterior circulation infarct 15 (7.9) 29 (25.7) <.0005 5 (20.0) .064
Mini-NIHSS score 9 (4-16) 7 (3-13) .442 14 (11-18) .005
Carotid artery territory stroke, n (%) 160 (84.2) 77 (68.1) .001 20 (80.0) .592
Vertebrobasilar artery territory
stroke, n (%)
21 (11.1) 35 (31.0) <.0005 5 (20.0) .165
ASPECTS or pcASPECTS (≥7) 159 (84.1) 87 (79.8) .345 16 (64.0) .014
Intravenous thrombolysis 90 (47.4) 4 (3.5) <.0005 1 (4.0) <.0005
Etiology
Cardioembolism, n (%) 92 (61.7) 51 (63.0) .856 13 (76.5) .233
Large-vessel disease, n (%) 7 (4.7) 6 (7.4) .285 2 (11.8) .223
Small-vessel disease, n (%) 17 (1.4) 11 (13.6) .631 0 (0) .144
Cryptogenic, n (%) 24 (16.1) 12 (14.8) .797 2 (11.8) .481
Follow-up mRS score (≤2), n (%) 64 (43.8) 34 (37.8) .359 2 (9.1) .001
Abbreviations: ASPECTS, Alberta Stroke Program Early CT Score; CT, computed tomography; mRS, modified Rankin scale; NIHSS, Na-
tional Institutes of Health Stroke Scale; OCSP, Oxford Community Stroke Project; pcASPECTS, posterior circulation ASPECTS; STW, stroke
within the therapeutic window; WUS, wake-up stroke; WUS≤3h, wake-up stroke with CT scan at 3 hours or less after awakening.
Continuous variables are presented as median (interquartile range).
Table 2. Multivariate analyses using binary logistic regression models
Variables included in the models Odds ratio (95% confidence interval) P value
ASPECTS (≥7) or pcASPECTS (≥7)
WUS≤3h (STW as reference group) .50 (.17-1.47) .208
Mini-NIHSS score (for each increment of 1 point) .83 (.77-.89) <.0005
mRS score (≤2)
WUS≤3h (STW as reference group) .53 (.09-3.14) .486
Age (for each increment of 1 year) .96 (.93-.99) .004
Mini-NIHSS score (for each increment of 1 point) .80 (.73-.87) <.0005
Intravenous thrombolysis 3.59 (1.40-9.22) .008
Abbreviations: ASPECTS, Alberta Stroke Program Early CT Score; mRS, modified Rankin scale; NIHSS, National Institutes of Health
Stroke Scale; pcASPECTS, posterior circulation ASPECTS; STW, stroke within the therapeutic window; WUS≤3h, wake-up stroke with CT
scan at 3 hours or less after awakening.
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ASPECTS and pcASPECTS, we used a time limit of 3
hours, which was defined as the time limit for throm-
bolysis in several studies.4 Lack of information on the
time since last known normal for patients with WUS may
limit the interpretation of data and may influence the
results of imaging studies. Similar to several ongoing ther-
apeutic trials for WUS, we used the time since symptom
recognition to select a subgroup of patients with WUS
comparable with patients with STW. Studies suggest that
WUS occurs predominantly in the early hours of the
morning1,8; therefore, the more suitable time point for de-
fining WUS onset and for defining a therapeutic window
may be that of symptom recognition rather than time since
last known normal. Our findings are in accordance to the
evidence that clinical and early CT findings in WUS pa-
tients are not different from patients with stroke of known
onset,9-13 and suggest that WUS may occur predomi-
nantly in a time period shortly before awakening. Selection
of WUS patients for thrombolysis based on “low-tech”
criteria, such as time from awakening-to-needle and quan-
tification of early signs of ischemia in CT,14 although having
the limitation of not providing information regarding pen-
umbra or definite core ischemic lesion may be sufficient
to guarantee safety of thrombolysis and more advanta-
geous regarding time to treatment, availability, and cost-
effectiveness. Independent predictors of favorable outcome
on short-term follow-up were age, severity of neurolog-
ical deficits, and thrombolysis, while recognition of
symptoms on awakening was not associated with a worse
mRS score on univariate (all WUS patients) or multi-
variate (WUS≤3h patients) analysis. The finding of a higher
frequency of vertebrobasilar circulation involvement in
WUS patients is intriguing and has previously been
unreported.9,10 This may be related to the fact that pa-
tients with minor deficits attributable to small carotid artery
territory lesions may have been discharged home from
the emergency department and therefore were not in-
cluded in our initial population of 554 patients. Our study
population had a high median age, explained by the fact
that we included all consecutive patients with ischemic
stroke admitted in our hospital, therefore reflecting daily
clinical practice in countries with increasingly older pop-
ulation. The main limitations of the present study are
related to its retrospective nature, which precluded col-
lection of systematic information on all NIHSS items for
all patients and prompted us to use a simplified version
of this scale. Similar modified NIHSS scales have been
published, and the validity for their retrospective use has
been shown,15,16 but their use limits the comparison with
other studies that use the standard version of NIHSS. Ad-
ditional limitations include exclusion of patients with minor
strokes who were not hospitalized, nonstandardized follow-
up, and small size population of WUS with early CT for
adequate imaging comparison with the control group.
In conclusion, this study shows that not only severity
of neurological deficits of WUS patients is similar to stroke
patients within the therapeutic window for intravenous
thrombolysis, but also frequency of absent or mild early
signs of cerebral ischemia on admission CT is compara-
ble in these 2 groups. Therefore, revascularization
treatments in the hyperacute phase, either intravenous
or intra-arterial, are likely to be safe in WUS patients,
and ongoing trials to study the benefit of these treat-
ments in this important group of patients may clarify which
are the most adequate clinical and imaging selection criteria.
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